Top 50 Life Science VC Funds & Investors in Germany (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
HTGF (High-Tech Gruenderfonds)
VC Fund
|
7 | Germany, Switzerland, United States | Seed, Series A | Software, Biotechnology, Information Technology | $909k–$40M |
|
coparion
VC Fund
|
5 | Germany, Switzerland, United States | Series A, Seed, Series B | Software, SaaS, FinTech | |
|
IFB Innovationsstarter
VC Fund
|
5 | Germany, United States | Seed, Grant | Software, SaaS, Artificial Intelligence | $80k–$3M |
|
Elevat3 Capital
VC Fund
|
3 | Germany, United Kingdom | Series A, Series B, Post-IPO Equity | FinTech, Apps, Social | $45M–$157M |
|
Lowercarbon Capital
VC Fund
|
3 | United States, United Kingdom, France | Seed, Series A, Series B | Renewable Energy, Energy, Biotechnology | $3M–$150M |
|
Good Seed Ventures
VC Fund
|
3 | Germany, Israel, United States | Seed, Series A, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $25k–$21M |
|
CPT Capital
VC Fund
|
3 | United States, Israel, United Kingdom | Series A, Seed, Series B | Food and Beverage, Biotechnology, Food Processing | $1.3M–$226M |
|
b.value AG
VC Fund
|
3 | Germany, Poland | Seed, Series A | Biotechnology, Manufacturing, Chemical | $478k–$40M |
|
Agronomics
VC Fund
|
3 | United States, Finland, Germany | Series A, Seed, Series B | Biotechnology, Food and Beverage, Food Processing | $894k–$55M |
|
Lima Ventures
VC Fund
|
3 | Turkey, United Kingdom, Estonia | Seed, Pre-Seed | Artificial Intelligence, Software, FinTech | $18k–$702k |
|
Grazia Equity
VC Fund
|
3 | Germany, United States, Switzerland | Series A, Series B, Seed | Internet, E-Commerce, Biotechnology | $1.1M–$59M |
|
Boehringer Ingelheim Venture Fund
VC Fund
|
3 | United States, Germany, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $1.3M–$50M |
|
Zee Prime Capital
VC Fund
|
2 | United States, Singapore, United Kingdom | Seed, Series A | Blockchain, Cryptocurrency, Information Technology | $1.9M–$43M |
|
Ananda Impact Ventures
VC Fund
|
2 | Germany, United Kingdom, Finland | Seed, Series A | Health Care, Software, Information Technology | $1.6M–$17M |
|
M Ventures
VC Fund
|
2 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
KfW
VC Fund
|
2 | Germany, India, Spain | Series A, Series B | Biotechnology, Software, Health Care | $2.2M–$17M |
|
Kurma Partners
VC Fund
|
2 | France, Switzerland, Spain | Series A, Seed, Series B | Health Care, Biotechnology, Medical | $2.3M–$80M |
|
Inflection
VC Fund
|
2 | United States, Germany, United Kingdom | Seed, Pre-Seed | Blockchain, Cryptocurrency, Software | $665k–$13M |
|
Die Brückenköpfe
VC Fund
|
2 | Germany, Austria | Seed, Series A, Pre-Seed | Health Care, Life Science, Therapeutics | $5.5M–$19M |
|
AQAL Integral Investing
VC Fund
|
2 | Germany, United States | Seed, Pre-Seed | Health Care, Medical Device, Medical | |
|
IBB Ventures
VC Fund
|
2 | Germany, United States, United Kingdom | Seed, Series A | Software, Health Care, SaaS | $1M–$9M |
|
Investitionsbank Berlin
VC Fund
|
2 | Germany, Canada | Grant, Seed | Software, Information Technology, Artificial Intelligence | $19k–$2.3M |
|
Lionheart Ventures
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A | Health Care, Biotechnology, Wellness | $25k–$46M |
|
Creathor Ventures
VC Fund
|
2 | Germany, Switzerland, United States | Series A, Series B | Software, Health Care, Biotechnology | $2M–$20M |
|
1kx
VC Fund
|
2 | United States, Germany, Switzerland | Seed, Series A | Blockchain, Cryptocurrency, Software | $1.8M–$28M |
|
Shine Capital
VC Fund
|
2 | United States, Spain, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Information Technology | $3.5M–$71M |
|
Amino Collective
VC Fund
|
2 | United States, United Kingdom, Germany | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Medical | $125k–$37M |
|
Happiness Capital
VC Fund
|
2 | Germany, United States, United Kingdom | Series A, Seed, Series B | Biotechnology, Food and Beverage, AgTech | $2M–$61M |
|
EQT Group
VC Fund
|
2 | Germany | Series A | Life Science, Biotechnology, Food and Beverage | $46M–$50M |
|
Cherry Ventures
VC Fund
|
1 | Germany, United Kingdom, United States | Seed, Series A, Series B | Software, Financial Services, Information Technology | |
|
LANA Ventures
VC Fund
|
1 | Austria | Seed | Apps, Medical, mHealth | |
|
PUSH VC
VC Fund
|
1 | Austria, Germany, United States | Seed, Series A | Software, Apps, Information Technology | |
|
Acurio Ventures
VC Fund
|
1 | Spain, United States, United Kingdom | Seed, Series A, Series B | Software, E-Commerce, Internet | |
|
Teknoloji Yatirim
VC Fund
|
1 | Turkey, United States, Germany | Seed, Series A, Convertible Note | Software, Machine Learning, Analytics | |
|
adesso ventures
VC Fund
|
1 | Germany | Seed, Series A | Software, Information Technology, Health Care | |
|
Qiagen
VC Fund
|
1 | Germany, United States | Seed, Series B | Biotechnology, Medical, Biopharma | |
|
Bool Capital
VC Fund
|
1 | Germany | Seed | Life Science, Biotechnology | |
|
Boom Capital Ventures
VC Fund
|
1 | United States, Canada, France | Seed, Series A, Pre-Seed | Biotechnology, Health Care, Artificial Intelligence | |
|
German Federal Ministry of Education and Research
VC Fund
|
1 | Germany, United States, Denmark | Grant, Seed, Series B | Biotechnology, Medical, Health Care | |
|
Abiomed
VC Fund
|
1 | United States, Germany, Israel | Series B, Series D | Medical Device, Health Care, Medical | |
|
hiVC
VC Fund
|
1 | Turkey, Germany | Pre-Seed, Series A | Education, Life Science, Food Delivery | |
|
Wille Finance
VC Fund
|
1 | France, Germany, Switzerland | Series A, Seed | Health Care, Software, Biotechnology | |
|
TGFS - Technologiegründerfonds Sachsen
VC Fund
|
1 | Germany, United States | Seed, Series A | Software, Information Technology, Manufacturing | |
|
Chorus One
VC Fund
|
1 | United States, Canada, Singapore | Seed, Series A | Blockchain, Cryptocurrency, Software | |
|
EIC Fund
VC Fund
|
1 | Germany, The Netherlands, Austria | Pre-Seed, Seed | Biotechnology, Health Care, Information Technology | |
|
JOT-Berlin
VC Fund
|
1 | Germany | Seed | News, Life Science, Social Media | |
|
Lunar Ventures
VC Fund
|
1 | United Kingdom, United States, Germany | Seed, Pre-Seed, Series A | Software, Information Technology, Artificial Intelligence | $35k–$14M |
|
Manouchehr Shamsrizis Alma Mater Capital
VC Fund
|
1 | Germany | Pre-Seed | Video Games, Life Science, Therapeutics | |
|
Project Flying Elephant
VC Fund
|
1 | Germany, France, United States | Seed, Angel, Convertible Note | Social Media, News, Apps | |
|
Inflection Capital
VC Fund
|
1 | Germany, United States | Seed, Pre-Seed, Series C | FinTech, Software, Blockchain | $2.3M–$6M |
| Access all 205 VC funds in Germany Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 550
- Round size: Seed $909k–$7.7M; Series A $3M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely still investing — raised $522M in 2022
Portfolio highlights
- Samp — Whatever the scale, age, or number of facilities, Shared Reality helps industrial operators accelerate their digital twin programs in an affordable and accessible way.
- FinMarie — FinMarie is an online financial platform for women for women in Germany. The firm supports clients with financial and wealth management projects and helps them find solutions appropriate for their personal situation.
- GeneQuine Biotherapeutics — GeneQuine Biotherapeutics designs and develops gene therapies for its clients. The therapies developed by the company aim to treat osteoarthritis. Its product portfolio consists of GQ-201, GQ-202, and GQ-203. GeneQuine Biotherapeutics was founded in 2011 by Stanislav Plutizki and Kilian Guse.
Coparion provides venture capital to accelerate momentum and growth. With a currently active fund of EUR 275 million, Coparion has the means to do so.Coparion supports entrepreneurial vision with know-how, but without intervening in daily business operations. Thanks to in-depth experience in venture capital and in building companies, the Coparionteam discerns potential and opens up new perspectives. Coparion has the substance, tenacity, and creativity required to mutually manage difficult situations successfully.Coparion only invests with co-investors. The fund invests up to EUR 15M per company, usually in several financing rounds of EUR 0.5-8M each. The investment focus is on German companies in the start-up and early growth phases. Coparion is based in Cologne and Berlin.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Series A, Seed, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 97
- Lead/follow: no public data
Portfolio highlights
- Finoa — Finoa is the leading European crypto-asset management platform, empowering businesses and institutions to engage with crypto safely and intuitively.
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Tubulis — Reimagining Antibody Drug Conjugates Tubulis generates uniquely matched protein-drug conjugates through the combination of novel proprietary technologies and disease-specific biologic insight. Our goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) by increasing design flexibility while overcoming constraints of toxicity, efficacy and indication. Tubulis will build new conjugates to fill its pipeline and
The IFB Innovationsstarter is an innovation funding and investment company of the City of Hamburg providing grants and investments.
Show more...Investment focus
- Industry: Software, SaaS, Artificial Intelligence
- Stage:Seed, Grant
- Geography: Germany, United States
Investor stats
- Total investments: 79
- Round size: Seed $658k–$3M; Grant $80k–$165k
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- mo:re GmbH — We offer standardized tissue cultures and protocols to better predict drug responses and investigate disease models.
- Flexvelop — Flexvelop combines financial technology with circular economy to add innovative values to the core function of equipment funding.Local vendors and online-shops integrate Flexvelop as a seamless embedded payment option. Business customers are now able to #flex new equipment per click right at the point of sale. Insurance is already covered, andour customers have now the weekly option, to buy- or return their equipment, easily. This enables a new world of worry-free and flexible business growth.We #flex business equipment from €300 up to €20.000 per item; e.g. coffee-machines, laptops, gym- or dental-equipment,... anything you need for your business.NEXT GENERATION PAYMENTS + Technological Innovation: fully automatic embedded payment option + Economical Innovation: optionality (rent/buy/return) + insurance included + Ecological Innovation: sustainability (contributing to a circular economy) = Enabling worry-free flexible business developmentForget renting. Forget leasing. Grow smart - flex it!
- eleQtron — eleQtron creates and operates quantum computers based on trapped ions, radio frequency control, and Magnetic Gradient Induced Coupling (MAGIC). It also puts forward novel ideas for scalable quantum processors based on RF-controlled trapped ions. eleQtron will run MAGIC quantum computers and provide quantum computing performance on a subscriptionbasis.
Elevat3 Capital is the venture capital arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group. With a focus on German-speaking countries, we partner with companies that meet our three-level criteria, then elevate them by providing more than just capital. We use our exceptional network, spanningindustry, politics, arts, science and technology, to give our portfolio companies access to high-profile leads and advisors, enabling them to grow rapidly and achieve amazing results.
Show more...Investment focus
- Industry: FinTech, Apps, Social
- Stage:Series A, Series B, Post-IPO Equity
- Geography: Germany, United Kingdom
Investor stats
- Total investments: 6
- Round size: Series A $45M–$157M
- Lead/follow: 83% lead, 17% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Naga — NAGA is disrupting the worlds of trading and investment by making them more open and inclusive. It is the single solution that's got it all: Trade, Earn, Invest, Acquire, Connect, Pay; all in one seamless and unified ecosystem that is radically social! Traders and investors from all around the world can use the NAGA technology every day inmany powerful ways: invest in the financial markets (physical stocks, CFDs in stocks, indices, currencies, energies, metals, commodities and cryptocurrencies), make payments in fiat and cryptocurrency, learn about wealth as well as communicate and connect with like-minded people anywhere and anytime. NAGA expands the one-of-a-kind experience with many other unique and innovative services such as the NAGA Mastercard, the AI-driven Portfolio baskets, the world’s first messenger where traders can exchange ideas and opinions in its public channels, Auto-Copying other traders and copying trading signals thanks to the revolutionary NAGA Signals feature.NAGA is really greater than the sum of its parts and powerful when its full spectrum of products and features are used together.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Lowercarbon Capital backs kickass companies slashing CO2 emissions, sucking carbon out of the sky, and buying us time to unf**k the planet.
Show more...Investment focus
- Industry: Renewable Energy, Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 186
- Round size: Seed $3M–$12M; Series A $10M–$50M; Series B $21M–$150M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $350M in 2022
Portfolio highlights
- Pledge — Pledge makes it simple for businesses of every size to measure, reduce and offset the climate impact of their products.
- Arbor Energy — A carbon removal and storage company delivering carbon-negative power.
- Lasso — Tender Food is a plant-based and cultured meat company in the Greater Boston Area, a hub for biotech research and innovation. It specializes in creating alternative meats with authentic textures.
Good Seed Ventures is a Venture Capital firm that exclusively invests in sustainable food tech.
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Israel, United States
Investor stats
- Total investments: 31
- Round size: Seed $25k–$7M; Series A $6.7M–$21M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Lovely Day Foods — We harness the power of plants and cutting-edge technology to crack the egg.
- Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI
- Nosh Biofoods — We create nutritional and highly functional proteins from non-GMO fungi. Our proprietary ferementation process is minimal, scalable, and sustainable.
Investing in the Future of Protein.We invest in visionary founders creating the future of food and materials.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 57
- Round size: Seed $1.3M–$7.5M; Series A $6M–$46M; Series B $15M–$226M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- Shiru — Discover Shiru. We are an Ingredient Company that Identifies and Creates Functional Ingredients for the Plant-Based Industry.
- Change Bio — Change Bio converts waste methane into proteins to make them more affordable and carbon-negative.
- Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
b.value AG are into Biotechnology investments.
Show more...Investment focus
- Industry: Biotechnology, Manufacturing, Chemical
- Stage:Seed, Series A
- Geography: Germany, Poland
Investor stats
- Total investments: 14
- Round size: Seed $478k–$2.5M; Series A $3M–$40M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- PL BioScience — STEM CELL EXPANSION IN SAFE AND REPRODUCIBLE CONDITIONS. We deliver advanced 2D and 3D cell culture solutions based on human Platelet Lysate – for basic research, cellular therapeutics and clinical applications. Choose between different safety grades meeting your needs: Research Grade, GMP Grade or GMP-Clinical Grade.
- Cultimate Foods — At Cultimate, we are transforming the flavor and aroma industry with natural innovative ingredients.
- traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Venture capital investment can raise funds for your small business. Venture Capital Firms in the UK like Agronomics is a biotech venture capital firm which invest into the clean meat sector.
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, Food Processing
- Stage:Series A, Seed, Series B
- Geography: United States, Finland, Germany
Investor stats
- Total investments: 44
- Round size: Seed $894k–$11M; Series A $6M–$47M; Series B $2.4M–$55M
- Lead/follow: 48% lead, 52% follow
Portfolio highlights
- BlueNalu — BlueNalu's mission is to be the global leader in cellular aquaculture, providing consumers with great tasting, healthy, safe, and trusted seafood products that support the sustainability and diversity of our oceans.
- Onego Bio — Onego Bio is a cell ag company, specialized in animal-free egg white protein. We produce bioalbumen with an innovative precision fermentation process.
- Liberation Bioindustries — Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech.
Collaboration with outstanding initiators with exceptional insights, from inception through all levels of progress. Lima Ventures supports visionary founders as well as provides certain services to early startups. We seek innovative technology-driven entrepreneurs who generate and lead companies that will inspire millions.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, FinTech
- Stage:Seed, Pre-Seed
- Geography: Turkey, United Kingdom, Estonia
Investor stats
- Total investments: 32
- Round size: Seed $18k–$702k
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- Shippn — International package forwarding service. Shop from Amazon, Shein, Macy's worldwide. Fast shipping with DHL & FedEx. Trusted by 50,000+ customers.
- heybooster — Heybooster is a provider of analytical tools to ecommerce companies to take better digital marketing decisions.
- Mars Studios — Mars Studios is an experienced team of growth hackers & marketers that can help you to increase your revenue. Rocket Your App to Success: Mars Studios
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Grazia Equity is a venture Capital firm investing in innovative, technology driven startups with high potential.Based in Stuttgart (Germany), Grazia has been supporting a large number of mostly young companies, often from their foundation to the Initial Public Offering or eventual sale. In contrast to other venture capital firms, theypredominantly work with their own capital that they invest as entrepreneurs.
Show more...Investment focus
- Industry: Internet, E-Commerce, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: Germany, United States, Switzerland
Investor stats
- Total investments: 83
- Round size: Seed $1.1M–$8M; Series A $1.1M–$53M; Series B $4M–$59M
- Lead/follow: 34% lead, 66% follow
Portfolio highlights
- GYANT — Create more capacity to care. Fabric is the care enablement system powering healthcare to move faster, work smarter, and deliver better care.
- XO Life — XO Life is to build the largest real-world evidence platform for patient insights for all medications and therapies. Together with one of Europe's leading research institutes for patient-centered research, the PROMIS Institute Germany of the Charité, and various pharmaceutical manufacturers, patient experiences are to be recorded in astandardized and systematic manner across a wide range of diseases. Patients are to be enabled to record their therapy course and outcome independently as well as scientifically validated so that these patient insights from real treatment practice can be used in the life science industry and by medical professions.
- Mister Spex — Mister Spex is an online store that sells various brands of glasses and contact lenses in Germany. Its product range includes over 5000 different glasses, sunglasses, sports eyewear, and contact lenses from more than 60 brands and designers.The store’s offerings include sports labels such as Adidas, Carrera, Lacoste, and Oakley to designer brandssuch as Burberry, Calvin Klein, Dolce&Gabbana, Gucci, Jil Sander, Prada, Roberto Cavalli, Tom Ford, and Versace.Mister Spex was launched in 2007 and its operations are headquartered in Berlin, Germany. It also operates its own websites in France, Spain, Austria, Switzerland, the Netherlands, and Great Britain.
Discover Boehringer Ingelheim Venture Fund. We invest in groundbreaking science to transform care. Explore our mission and join us in advancing medicine
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 96
- Round size: Seed $1.3M–$20M; Series A $3.8M–$34M; Series B $11M–$50M
- Lead/follow: 47% lead, 53% follow
- Last fund: May invest from a new fund soon — raised $250M in 2018
Portfolio highlights
- Perfood — Perfood is a digital therapeutic startup that identifies what actions need to take on a personalized level, to prevent or fight diseases. Using sensors, lab results, and holistic analyses, they derive therapeutic angles and deliver them in a slick, easy-to-use way, making them accessible for all patients. They call this approach digitaltherapeutics. A digital solution that is just as effective as a drug. But without side effects.
- ArrePath — ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
Totally supercool and chilled VC investing in programmable assets, collaborative intelligence and other buzzwords.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Information Technology
- Stage:Seed, Series A
- Geography: United States, Singapore, United Kingdom
Investor stats
- Total investments: 79
- Round size: Seed $1.9M–$9M; Series A $2.8M–$43M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Biconomy — Blockchain transactions made simple. Enable Gasless meta-transactions, instant cross-chain transfers, easy layer 2 onboarding & zero failed transactions
- Ceramic Network — Ceramic Network is a provider of protocols for decentralized and composable data applications. The network decentralizes application databases, making data universally composable and reusable across applications. It consists of three core parts: a highly-scalable, decentralized infrastructure for data availability and consensus, a marketplace ofcommunity-created data models, and a suite of standard APIs for storing, updating, and retrieving data from those models.
- Pocket Universe — Pocket Universe is a browser extension that keeps your assets safe when you sign web3 transactions
We are the home for entrepreneurs with a big vision who want to create something less ordinary. Something that matters. For all of us.
Show more...Investment focus
- Industry: Health Care, Software, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United Kingdom, Finland
Investor stats
- Total investments: 71
- Round size: Seed $1.6M–$17M; Series A $3.8M–$17M
- Lead/follow: 42% lead, 58% follow
- Last fund: Likely still investing — raised $121M in 2022
Portfolio highlights
- DrDoctor — We envision a remote-first healthcare system which meets demand without sacrificing care quality, delivered via our Patient Engagement Platform
- Xperiome — Match research-ready members to clinical and real-world studies, faster and smarter than ever before through data-driven insights into the rare disease experience.
- AIRMO — Airmo is a space tech company that offers an independent data source that locates, quantifies, and tracks carbon dioxide and methane emissions through a small satellite constellation.
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 165
- Round size: Seed $2.4M–$21M; Series A $5.6M–$46M; Series B $15M–$100M
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- NanoSyrinx — NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein nanosyringes as a completely novel modality for intracellular delivery of protein and peptide biologic drugs.
- Rewind Therapeutics — Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.The company's first-in-class remyelinating therapeutics block inhibitory signals that prevent the expansion and migration of oligodendrocyte stem cells in order to promote effective remyelination, enabling medicalpractitioners to treat patients suffering from multiple sclerosis and other myelin-related diseases with efficacy.
- Prexton Therapeutics — Voici la page d'accueil du site web
KfW gives impetus to economic, social and ecological development worldwide. As a promotional bank under the ownership of the Federal Republic and the Länder (federal states), it offers support to encourage sustainable improvement in economic, social, ecological living and business conditions, among others in the areas of small and medium-sizedenterprise, entrepreneurialship, environmental protection, housing, infrastructure, education finance, project and export finance, and development cooperation.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Series A, Series B
- Geography: Germany, India, Spain
Investor stats
- Total investments: 142
- Round size: Series A $2.2M–$7.7M; Series B $3.3M–$17M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Power Finance Corporation — Power Finance provides financial products and related advisory, and other services to the power sector in India. It offers fund based financial policies/products, including asset acquisition; bridge, corporate, short term, and rupee and foreign currency term loans; short term loan for SPV; buyer’s line of credit; and credit facility forpurchase of power. Power Finance's fund based financial policies/products also include debt refinancing; energy saving projects; fuel supply projects and equipment manufacturers financing; grants/interest free loans for studies/consultancies; lease financing for wind power projects and purchase of equipment; line of credit for import of coal; takeout financing; and solar PV policy to private sector. Its non-fund based products comprise guarantee, guarantee for credit enhancement, and letter of comfort. Power Finance also provides consultancy services in the areas of procurement of power by distribution licensees; renewable and non-conventional energy schemes; selection of developers for coal blocks; selection of EPC contractors; reform, restructuring, and regulatory aspects; capacity building and human resource development; and execution of ultra-mega power projects, and independent transmission projects. It serves state electricity boards, state power utilities, central power sector utilities, power departments, equipment manufacturers, private power sector utilities, joint sector power utilities, and other state departments engaged in the development of power projects. Power Finance began operation in 1986. It has its headquarters in New Delhi in India.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Grenergy Renovables — Entwicklung von Photovoltaik und Speicher Projekten und Speicher Projekten mit Grenergy. Willkommen bei Grenergy
Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Seed, Series B
- Geography: France, Switzerland, Spain
Investor stats
- Total investments: 129
- Round size: Seed $2.3M–$13M; Series A $3.8M–$74M; Series B $8.8M–$80M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts.
- Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
- Vico Therapeutics — Pioneering RNA-based science to target the root cause of rare genetic neurological diseases VO659: The first clinical candidate directly targeting the CAG repea
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Pre-Seed
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 34
- Round size: Seed $2M–$13M; Pre-Seed $665k–$4.3M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Ubitium — Ubiquitous computing, universal RISC-V microprocessor
- Nordic Air Defence — Nordic Air Defence builds cutting-edge solutions for modern aerial security. Made in Sweden.
- Fabric Cryptography — Fabric develops a custom cryptography hardware to accelerate cryptography algorithms. The chips, whose components exclusively serve cryptographic purposes, are based on Verifiable Processing Units (VPUs) which incorporate features of GPUs and ASICs to improve the speed and cost of advanced cryptographic workloads.
Die Brückenköpfe is a management consulting and investing firm focused on the German healthcare market.
Show more...Investment focus
- Industry: Health Care, Life Science, Therapeutics
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria
Investor stats
- Total investments: 7
- Round size: Series A $5.5M–$19M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- anvajo — Lab diagnostics for everyone, everywhere. Understanding fluids through light and algorithms
- Skinuvita — Skinuvita specializes in developing digital home treatment solutions for chronic autoimmune skin diseases such as psoriasis, atopic dermatitis, and vitiligo. Utilizing specific wavelengths of UV light (311nm) that have a calming effect on skin's immune cells responsible for inflammation, Skinuvita's approach to phototherapy aims toimprove the quality of life for patients. The company offers a patient app that guides users through therapy sessions and analyzes responses for dosage optimization, alongside tools for dermatologists to monitor treatment progress. This innovative approach allows for effective management of skin conditions from the comfort of one's home.
- Recare — Recare developed a software platform for discharge management and supply control in hospitals and other medical facilities. With its B2B marketplace, Recare is trying to end the paperwork in the German healthcare system.
Munich-based AQAL Group is an active technology and impact holding company using the Integral Investing approach. Focus: exponential technology and digital evolution (Internet infrastructure, artificial intelligence, blockchain & financial tech, B2B IT solutions, Industry 4.0), green technology (renewable energy, energy efficiency, cleantech, circular economy), and life in the 21st century (future mobility, food, life science, med tech, media & entertainment tech).
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Pre-Seed
- Geography: Germany, United States
Investor stats
- Total investments: 11
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
- wondder — Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy, successful, productive teams. Experience the power of wondder. Contact Us Empowering People through Virtual Reality Use our training in Virtual Reality to create more happy,
- Elona Health — Elona Health creates digital solutions that shape tomorrow's psychotherapy and support patients and therapists alike.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Pre-Seed to Series A for Berlin-based founders. Where 30 years of expertise, capital and execution power meet.
Show more...Investment focus
- Industry: Software, Health Care, SaaS
- Stage:Seed, Series A
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 209
- Round size: Seed $1M–$4.6M; Series A $2.2M–$9M
- Lead/follow: 18% lead, 82% follow
- Last fund: Likely still investing — raised $33M in 2022
Portfolio highlights
- Vara — Vara AI brings radiologists clinically proven, CE-marked intelligence, so cancers are detected earlier and every read is more confident.
- eduBITES — eduBITES provides a new university and corporate learning experience.
- Likeminded — Likeminded developed a digital platform for mental health that gives people fast, low-threshold access to psychological support.
Investitionsbank Berlin (IBB) is the subsidy bank of the Federal Land of Berlin. With its newly orientated economic support and subsidy policy, it actively contributes towards developing Berlin as a business and industry location.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Grant, Seed
- Geography: Germany, Canada
Investor stats
- Total investments: 57
- Round size: Seed $598k–$2.3M; Grant $19k–$1.4M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- Quantune — Quantune is a deep tech startup in optics and photonics technology. It develops laser spectrometer for continuous and non-invasive health monitoring.
- CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
- muffintech — Generative AI for the insurance industry. Unleash the full potential of your employees and offer your customers an unmatched user experience.
Lionheart Ventures is a global, seed-stage venture capital firm focused on mitigating civilizational risk. We do this by supporting the wise development of transformative technologies. Our main areas of investment focus are transformative artificial intelligence and frontier mental health technologies.Leading academics estimate a 1-in-6 chance ofhuman extinction by the year 2100, largely driven by risks from emerging technologies. And now, with the exponential growth of AI, predictions are getting worse. Our startups are part of the solution. We invest in exceptional, ethical founders who are developing transformative technologies that have the potential to impact humanity on a meaningful scale, while generating attractive returns for our LPs.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Wellness
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 39
- Round size: Seed $1.6M–$11M; Series A $25k–$46M
- Lead/follow: 3% lead, 97% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
- Piramidal — Piramidal offers artificial intelligence software that transforms brain activity into easy-to-understand health data to help diagnose neurological diseases.
- Clerkenwell Health — Clerkenwell Health addresses the growing unmet demand for effective mental health treatments.
We have been investing at the frontier of technology and science for over 30 years. We know what it takes to succeed.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: Germany, Switzerland, United States
Investor stats
- Total investments: 93
- Round size: Series A $2M–$12M; Series B $5.1M–$20M
- Lead/follow: 41% lead, 59% follow
- Last fund: May invest from a new fund soon — raised $94M in 2016
Portfolio highlights
- SIRION BIOTECH — Viral Vector Technology as key enabler for innovative therapeutics. Viral vectors are a tool commonly used by molecular biologists to deliver genetic material into cells. This technique enables research of gene function and innovative therapeutics designed to correct defective genes and cancer. These technologies also assist in the discovery ofnew drug, food and cosmetic compounds. SIRION is a global leader in viral vector technology for gene modification of mammalian cells. Along with custom services, the company stands ready to outlicense its unique technologies. An initial target currently being pursued by one of SIRION's partners is a gene therapeutic for cervical cancer. The company started business in 2007 and since then has been changing the paradigm of viral vector supplies. Specifically, all commonly applied vector types are now available within a matter of weeks - adenovirus, adeno-associated virus (AAV) and lentivirus - and a full range of virus related services is at your fingertips spanning from particle production to virus driven cell modelling, all at highest titers and in quantities required for preclinical, clinical and animal testing.The company is easily accessible with presence in Munich, Tokyo, New Hampshire and Tel Aviv. Commercial arrangements range from fee-for-service over exclusive rights on single clones all the way to milestone & licensing arrangements. The business model proves successful: an annual 70% growth since 2007 and experienced in more than 500 projects for both the academic and industry sector.The company is privately held and has over the years raised funds from 8 investors both private and government. In order to support further growth and to benefit from technology development in this exciting industry, the company welcomes new investors. Please contact Management for further information about the company and its future plans.
- CryoTherapeutics — CryoTherapeutics is focusing on the development, demonstration of clinical benefit, and early-stage commercialization of a proprietary cryotherapy system for use in the treatment of coronary artery disease that causes heart attacks. The safety and efficacy of cryoenergy in the cardiovascular system has been demonstrated and CryoTherapeutics intendsto extend the benefits of cryoenergy to the problem of diseased coronary arteries.
- Chundsell Medicals — Chundsell Medicals AB was founded in 2007 as a spin off from Karolinska Institutet, Solna, in order to commercialize the research results of Chunde Li and his group on prostate cancer genomics. The first product: The Prostatype® Test System can assess prostate cancer aggressiveness in conjunction with currently used clinical parameters. TheProstatype® Test System measures the expression pattern of three selected and specific prostate cancer embryonic stem cell genes in tumor cell tissue specimens. These expression patterns together with a group of a selected number of known clinical parameters will help the health care professional to predict the disease outcome, the overall survival as well as cancer specific survival of patients.
1kx is an early-stage investment firm focused on ecosystem growth.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 155
- Round size: Seed $1.8M–$11M; Series A $6M–$28M
- Lead/follow: 46% lead, 54% follow
Portfolio highlights
- Bluff —
- Ligero — Ligero is a blockchain privacy startup
- Inco — Inco is the final layer of the blockchain stack, empowering smart contracts with confidentiality to unlock use cases and enable widespread web3 adoption.
Shine is an early-stage venture capital firm that partners with creative, convincing, relentless entrepreneurs to build iconic businesses.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United States, Spain, Canada
Investor stats
- Total investments: 67
- Round size: Seed $3.5M–$18M; Series A $12M–$25M; Series B $10M–$71M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $100M in 2022
Portfolio highlights
- Mentra — Mentra tackles systemic inequality by economically empowering underserved communities. We’re erasing the stigma around Disability Hiring with our recruiting platform that matches neurodiverse talent with inclusive employers.Our mission is to bring neurodiversity to the workplace - providing employers with thought diversity & job seekers witheconomic opportunity
- Rose Rocket — Rose Rocket's transportation management software (TMS) helps trucking companies and freight brokers improve visibility, collaboration, and efficiency.
- Supergood Systems — Generate fully managed tools your agents can call at scale. Ultra fast, reliable and observable. Skip the browser entirely.
Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 43
- Round size: Seed $2.4M–$15M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- Anima — Anima's online patient triage speeds up the clinical workflow 10x and allows providers to deliver the right care for patients within 24 hours.Millions of patients with serious problems are missed and die every year because there isn’t adequate information flow between medical appointments. Patients submit their problems and requests onAnimainstead of waiting for an appointment, and Anima sends an actionable report to their provider with trends, risks and recommendations.
- Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
- Kenbi — Lovable Generated Project
We invest in startups and VC funds that share our values across crucial sectors for the planet backed by a global network of entrepreneurs and scientists working towards a happier future
Show more...Investment focus
- Industry: Biotechnology, Food and Beverage, AgTech
- Stage:Series A, Seed, Series B
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 29
- Round size: Seed $2M–$11M; Series A $10M–$46M; Series B $8.8M–$61M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- Innovacell — Innovacell is a biotechnology firm entirely focused on the area of tissue engineering and it operates one of Europe's largest and most modern production facilities for the proliferation of the body's own tissue cells. Its supervisory board is chaired by the experienced financial expert, Dr. Harald Pöttinger, a director of Alpine EquityManagement AG, based in Bregenz, Austria. Innovacell currently employs 20 staff as well as numerous outside experts.
- Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.
EQT is an investment organization committed to creating value by finding good companies and helping them become the most promising builders of tomorrow.
Show more...Investment focus
- Industry: Life Science, Biotechnology, Food and Beverage
- Stage:Series A
- Geography: Germany
Investor stats
- Total investments: 2
- Round size: Series A $46M–$50M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Formo — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
- Legendairy Foods — Formo is shaping the future of dairy with precision fermentation, creating animal-free recombinant milk proteins with exceptional functionality.
Cherry Ventures is an early-stage venture capital firm led by a team of entrepreneurs with experience building fast-scaling companies such as Zalando and Spotify. The firm backs Europe's boldest founders, usually as their first institutional investor, and supports them in everything from their go-to-market strategy and the scaling of theirbusinesses. Cherry Ventures has previously invested in the seed stage of over 50 companies across Europe, including FlixBus, Auto1 Group, Infarm, Rows, Forto, and TourRadar. Cherry Ventures is based in Berlin and invests across Europe with operations in London, Paris, and Stockholm.
Show more...Investment focus
- Industry: Software, Financial Services, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Germany, United Kingdom, United States
Investor stats
- Total investments: 213
- Lead/follow: no public data
Portfolio highlights
- Tola — Tola offers a simple and easy way for businesses to pay and get paid, however and whenever they want. Sign up today!
- Qura — Qura builds AI to make legal text searchable using natural language.
- Atlas Metrics — The single source of truth for your ESG data
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!LANA Ventures is a venture capital firm.
Show more...Investment focus
- Industry: Apps, Medical, mHealth
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- XUND — Answer the most important health questions with AI-powered technology from XUND. Medically certified and CE marked.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
| Investments that move industries
Show more...Investment focus
- Industry: Software, Apps, Information Technology
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 33
- Lead/follow: no public data
Portfolio highlights
- Podero — Podero energy flexibility software helps utilities steer devices, trade their flexibility on spot and balancing markets and launch new energy products.
- UniteLabs — UniteLabs provides the foundational operating system for AI-driven lab automation in life science. It accelerates scientific discovery by closing the loop with a unified data and automation infrastructure, seamless integration, and intelligent control. Our platform empowers ambitious biotech companies, big pharma, integrators, and hardware vendorsby offering bidirectional connectors for diverse lab equipment, a scalable cloud platform with an open API, and a powerful workflow engine with an integrated compute environment. This allows for the creation of sophisticated, modular workflows, and enables rapid automation development through our Lab-as-Code environment, featuring a dynamic Python SDK and application-specific libraries.
- Circonomit — Building the world's environmental data infrastructure - We are the sustainability counterpart to what Excel, Sheets and Datev are to financial planning and accounting. Our mission is to create the first decision intelligence platform to bridge sustainability and finance by building the global standard for the collection and aggregation ofcorporate environmental data.
Acurio Ventures partners with visionary founders to make history happen. Acurio Ventures is a European early-stage VC that invests across sectors and business models and that relies on its entrepreneurial DNA, flexible approach and proven value add to partner with the best founders out there.
Show more...Investment focus
- Industry: Software, E-Commerce, Internet
- Stage:Seed, Series A, Series B
- Geography: Spain, United States, United Kingdom
Investor stats
- Total investments: 105
- Lead/follow: no public data
Portfolio highlights
- Lexroom.ai — Lexroom.ai allows lawyers to complete hours of legal research in seconds.Legal professionals spend up to 50% of their time in repetitive, low value-adding tasks. That’s why we’re building Lexroom.ai, a product that allows lawyers to complete hours of research in seconds, so they can focus on what really matters.Lexroom.ai perfectly integrateswith lawyers' daily workflow and enables them to speed up time-consuming legal research tasks while increasing output quality, so that they can focus more on value-adding activities.Lexroom.ai is building a bridge between advanced artificial intelligence technologies and legal professionals, through a product specifically tailored to their needs.
- Those Beyond — Those Beyond develops a social gaming platform that supports interactive fan experiences within fictional universes. The platform uses its proprietary Arise Engine to enable browser-based adventures, role-playing, and puzzle-solving activities involving mass community participation. Projects include collaborations with entertainment franchises suchas "The Walking Dead," allowing fans to engage with story-driven challenges and community events. The platform includes customizable social spaces designed to reflect the themes and aesthetics of the associated intellectual properties.
- Phagos — Phagos uses AI and phages to create personalized bacterial treatments in 2 months. Our sustainable antibiotic alternative targets specific bacteria without resistance, serving chicken, cattle, swine, and shrimp farms worldwide.
Teknoloji Yatırım is the first actor investing in early-stage technology companies in Turkey. Aiming at preparing the venture capital ecosystem for new players, Teknoloji Yatırım designs, develops and manages innovative tools to meet the financing needs of technology companies in the early and growth stages. What We Do: - Direct Investments: Wemake equity investments to technology companies having internationalization potential. - Co-Investments and Follow-on Investments: We make co-investments and follow-on investments to technology companies at scaling and growth stages, together with other Venture Capital Funds. - Consultancy Services: We offer consultancy solutions in the design, implementation and management of innovative investment tools and models.
Show more...Investment focus
- Industry: Software, Machine Learning, Analytics
- Stage:Seed, Series A, Convertible Note
- Geography: Turkey, United States, Germany
Investor stats
- Total investments: 19
- Lead/follow: no public data
Portfolio highlights
- Cellsway — Cellsway is a liquid biopsy company that was created to provide quick cancer CTC detection methods. The business's technology, which is minimally invasive and uses a straightforward blood sample for cancer monitoring, enables healthcare professionals to heal their patients and enhance their quality of life. focuses on the development ofmicrofluidics and lab-on-a-chip technologies for biomedical purposes.
- BRANDEFENSE — Brandefense platform is a proactive digital risk protection solution for organizations. Our AI-driven technology constantly scans the dark, deep, and surface web.
- Mindsite — Mindsite provides e-commerce analytics. Easily monitor key metrics from price to visibility in real time. Increase your online sales.
Der Inkubator der adesso Group - Was du brauchst und was wir dir bieten.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Germany
Investor stats
- Total investments: 13
- Lead/follow: no public data
Portfolio highlights
- Acto — Acto is a SaaS software provider that caters to B2B sales leaders. The company leverages artificial intelligence to automate data analytics, providing valuable insights to sales teams about potential risks and opportunities in account management. Acto's platform is designed to enhance the performance of sales teams and drive business growth.It links all data in one place and proactively informs teams about sales opportunities and risks in their customers. This eliminates the need for lengthy searches in Excel reports and allows for a more streamlined and efficient sales process.
- Noah Labs — A breakthrough for heart failure: Noah Labs Ark is a Class IIa Medical Device Software with AI-driven detection of early cardiac decompensation through voice.
- Flowstep — Flowstep is a copilot that helps you create better designs, 10x faster. Just type and get user flows, high-fidelity UI, JTBD and more.
QIAGEN delivers Sample to Insights solutions that enable customers to unlock insights from the building blocks of life - DNA, RNA and proteins.
Show more...Investment focus
- Industry: Biotechnology, Medical, Biopharma
- Stage:Seed, Series B
- Geography: Germany, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Actome — Actome focuses on developing emulsion coupling technology for life science research and personalized medicine.
- Protagen — Protagen is a precision medicine specialist that support drug development, facilitate treatment strategies and improve patient management. Protagen is at the forefront of immuno-profiling and the discovery of novel autoantibody signatures for autoimmune disease and immuno-oncology. Protagen’s SeroTag® technology identifies biomarkers that address anumber of challenges currently hindering the successful development and broader application of both cancer immunotherapies and novel treatments for autoimmune diseases.The company is a leader in patient stratification for autoimmune disease, having developed disease-specific NavigAID stratification panels that profile individual patient’s autoimmune condition and immune status. This precision medicine approach allows for the development and implementation of more targeted therapies for diseases such as systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), Sjögren’s syndrome (SjS) and others.
- Coley Pharmaceutical Group — Coley Pharmaceutical Group operates as a biopharmaceutical company developing therapeutics and drug candidates that direct the human immune system to fight cancers, asthma and allergy, autoimmune disorders, and to enhance the effectiveness of vaccines. The company was formerly known as CpG ImmunoPharmaceuticals, Inc. and in August 2000 it changedits name to Coley Pharmaceutical Group, Inc. The company was founded in 1997 and is based in Wellesley, Massachusetts. As of December 28, 2007, Coley Pharmaceutical Group, Inc. operates as a subsidiary of Pfizer Inc.
Bool Capital is a private investment firm that builds deep-tech ventures in cloud infrastructure, blockchain, cybersecurity.
Show more...Investment focus
- Industry: Life Science, Biotechnology
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- DNTOX — We are building up a bioanalytical testing laboratory for animal-free screening of chemicals, regarding their potential to disturb brain development and cause developmental neurotoxicity (DNT). Our in vitro testing battery is based on human cell models and enables chemical screening in a high-content and medium-throughput fashion. Furthermore, itis supported by an in-house developed software, using artifical intelligence. We support our customers during the identification of safe lead structures during substance development, as well as the safety assessment during approval and re-approval processes of chemicals. With our innovation, we want to realize our company vision: Safe chemicals without animal experiments!
Boom Capital is a pre-seed fund for deeply technical, under-networked founders trying to build their companies. It was incorporated in 2017 and is based in San Francisco, California.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, Canada, France
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Bioptimus — Our mission is to build the first universal AI foundation model for biology to fuel breakthrough discoveries and accelerate innovations in biomedicine and beyond.
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Waypoint Bio — Waypoint's proprietary spatial multi-omics platform enables us to solve critical issues around understanding how cell therapies navigate the three-dimensional tumor microenvironment and allow the measurement of cell-to-cell interactions.
The German Federal Ministry of Education and Research funds research programs and institutions, supervises nuclear energy, and establishes educational policy in general.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Grant, Seed, Series B
- Geography: Germany, United States, Denmark
Investor stats
- Total investments: 58
- Lead/follow: no public data
Portfolio highlights
- NetBird — Wiretrustee is an open-source VPN platform built on top of WireGuard® making it easy to create secure private networks for your organization or home. It requires zero configuration effort leaving behind the hassle of opening ports, complex firewall rules, VPN gateways, and so forth.
- CyberTide — CyberTide is an AI-based Data Leak Prevention Solution
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Abiomed is a provider of mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufacture and market products that is designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. The Company's productsare used in the cardiac catheterization lab (cath lab) by interventional cardiologists and in the heart surgery suite by heart surgeons for patients who are in need of hemodynamic support prophylactically or emergently before, during or after angioplasty or heart surgery procedures.
Show more...Investment focus
- Industry: Medical Device, Health Care, Medical
- Stage:Series B, Series D
- Geography: United States, Germany, Israel
Investor stats
- Total investments: 8
- Lead/follow: no public data
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Impulse Dynamics — Impulse Dynamics is a medical device company dedicated to offering innovative solutions for treatment of Chronic Heart Failure (CHF). The Company’s developments are based on its proprietary technology for administering Cardiac Contractility Modulation therapy. This form of treatment has been shown in European clinical trials to produce an immediateand powerful modulating effect on cardiac cells, resulting in clinically meaningful increases incardiac performance.Impulse Dynamics is spearheaded by a team of professionals including, scientists, physicians, and engineers. The Company carries out research programs in major universities and hospitals throughout the world, and is currently engaged in clinical trials in Europe and in the United States. The Optimizer with Cardiac Contractility Modulation therapy, is CE marked. See Clinical Data for more information.
- Shockwave Medical — Shockwave Medical is a Cardiovascular Medical Device Company changing how calcified cardiovascular disease is treated with Intravascular Lithotripsy (IVL).
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!hiVC is an early-stage venture capital that connects early-stage startups with winning business models to achieve global success.
Show more...Investment focus
- Industry: Education, Life Science, Food Delivery
- Stage:Pre-Seed, Series A
- Geography: Turkey, Germany
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- VRLab Academy — VRLab Academy | Virtual Experiments
- Mizanplus Kitchens — Mizanplus Kitchens provides delivery service multi-brand dark store network.
An international, Swiss-based family office, focusing on private equity (venture & buy-out), real estate and listed assets.
Show more...Investment focus
- Industry: Health Care, Software, Biotechnology
- Stage:Series A, Seed
- Geography: France, Germany, Switzerland
Investor stats
- Total investments: 36
- Lead/follow: no public data
Portfolio highlights
- Mediaire — mediaire supports radiologists with AI-based tools for MRI reporting. This enables them to make a more accurate and objective assessment even faster.
- Newronika — Newronika restores brain and body functions with innovative technologies. We translate our deep knowledge on biosignal decoding into clinical practice, with the aim of improving treatments, health, and wellness. With our revolutionary brain devices, the patient receives the right stimulation at the right moment, thus becoming able to perform normaldaily activities and improve quality of life. Newronika is the spin-off company of two leading research institutions in Italy, the Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Hospital and the University of Milan. Newronika comprises a multidisciplinary team formed from Neuroscience research groups and involves scientists with expertise in neurophysiology, neurology, biomedical engineering, neuropsychology, bioinformatics, and biotechnologies.
- Happydemics — Happydemics is the story of frustration become conviction. A frustration with the complexity of market research, neglected by decision-makers in favor of a simplistic and stereotypical vision of a target. But Happydemics is above all the conviction that they must reinvent the experience of studies for brands, but also for respondents, bydemocratizing access to the opinion of all people. Happydemics was born, and 5 years later, Their conviction is stronger every day!
TGFS - Technologiegruenderfonds Sachsen is an early stage VC fund targeting high tech startups with strong growth potential. The fund invests into ventures located in Saxony/Germany, Europe's leading semiconductor cluster. The team has invested into more than 120 companies so far, including more than 40 investments from the currentfund.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States
Investor stats
- Total investments: 118
- Lead/follow: no public data
Portfolio highlights
- MiViA — From microstructure segmentation to grain size measurement! Our AI engine provides a fast and reliable metallographic analysis for metallic products.}
- BeeOLED — BeeOLED’s technology enables OLED displays with significantly improved efficiency, brightness and operational stability at lower overall costs due to a less complex device structure.
- volytica diagnostics — Our software enables customers to develop more economical battery systems, reduce operational risks and establish second-use concepts.
Chorus One is offering staking services and building tools and protocols to advance the Proof of Stake ecosystem.
Show more...Investment focus
- Industry: Blockchain, Cryptocurrency, Software
- Stage:Seed, Series A
- Geography: United States, Canada, Singapore
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Keplr — Introducing the first, and leading, IBC-enabled wallet for Cosmos and beyond
- FastLane — The Alignment Layer of Monad - shMonad is the holistic LST returning value to Nads, apps, and validators
- Fortytwo — Fortytwo is a decentralized AI network that employs swarm intelligence by linking consumer devices to execute small AI models. It provides a scalable and cost-efficient alternative to centralized AI systems, enabling users to contribute computing resources while ensuring data privacy. Fortytwo's goal is to create a reasoning engine thatoperates on a planetary scale and is driven by the community.
start-ups, SMEs, technology, co-investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Germany, The Netherlands, Austria
Investor stats
- Total investments: 22
- Lead/follow: no public data
Portfolio highlights
- Filuta AI — Operationalized Composite Artificial Intelligence
- Resistell AG — Resistell is a antibiotic resistance test.
- iThera Medical — Explore optoacoustic imaging technology for non-invasive in vivo visualization and quantification of disease-related tissue biomarkers.
Jot-Berlin is a group of angel investors.
Show more...Investment focus
- Industry: News, Life Science, Social Media
- Stage:Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Labiotech.eu — Labiotech.eu covers the global biotech industry, read by 150,000+ monthly visitors. Hope you'll enjoy our Biotech News!
Lunar Ventures is a deep-tech, seed-stage venture fund with a team of 3 deep-tech expert partners in Berlin that come from science, and business in deep tech companies. The firm particularly invests across Europe into founders building high potential startups that specialize in artificial intelligence or machine learning, blockchain,cybersecurity, big data, analytics, or other industries.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 35
- Round size: Seed $1M–$7.8M; Pre-Seed $35k–$2.5M; Series A $2.5M–$14M
- Lead/follow: 34% lead, 66% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Neurolabs — Neurolabs helps puts an end to out-of-stocks using a powerful combination of computer vision and synthetic data, improving customer experience and increasing revenue.
- Wasp — A simple language for developing full-stack web apps with less code.
- Runware — Run AI models with the lowest-cost API for developers. Fast, flexible access to generative models for image, video, audio, LLM, 3D, and more.
Holding von Manouchehr Shamsrizi, Gründer
Show more...Investment focus
- Industry: Video Games, Life Science, Therapeutics
- Stage:Pre-Seed
- Geography: Germany
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- RetroBrain R&D GmbH — Memore gamifies proven dementia therapies into a gesture controlled medical video game. It incorporates and gamifies proven therapies, delaying the effects of dementia and mild cognitive impairment, enabling elderly people without prior gaming experience to utilize the gaming suite easily.Memore works both therapeutically and preventatively withnursing rehabilitation. It was founded in 2014 and is based in Hamburg, Germany.
WestTech Ventures is a Berlin-based VC firm focused on pre-seed & seed investments primarily in Germany in the fields of B2B SaaS in different verticals, and Enterprise Software as well as Mobility and New Work.
Show more...Investment focus
- Industry: Social Media, News, Apps
- Stage:Seed, Angel, Convertible Note
- Geography: Germany, France, United States
Investor stats
- Total investments: 4
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Krak — Make more skateboarding happen in the world.
- HashtagNow — HashtagNow is the real-time news platform that uses hashtags to discover and provide context for topics people talk about across platforms.
- Labiotech.eu — Labiotech.eu is the leading digital media covering the European Biotech industry. Read it to keep a watch on the business and innovations of biotechnologies. Join us now and enjoy reading our stories!
Inflection is a first check venture capital firm exploring new frontiers. We run nodes, govern DAOs and write code. We invest between $500k-$1.5M initially and have a global mandate.
Show more...Investment focus
- Industry: FinTech, Software, Blockchain
- Stage:Seed, Pre-Seed, Series C
- Geography: Germany, United States
Investor stats
- Total investments: 9
- Round size: Seed $2.3M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Centrifuge — Centrifuge is the platform for tokenized real-world assets, providing the infrastructure and ecosystem to tokenize, manage, and invest into RWAs.
- Maker Wine — Craft canned wine, delivered to you. Maker works with the best small producers to bring you award-winning, zero sugar, minimal intervention wines in cans.
- Unstoppable Finance — The leading wallet for trading on decentralized exchanges, DeFi and NFTs. Pro charts. Lightning fast. Zero Fees. Live on Solana and Ethereum on iOS and Android.
Life Science VC funding in Germany at a glance
Stats across 119 deals from 205 investors.
Access all 205 VC funds in Germany Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science VC Funds in Germany investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 205 VC funds investing in Germany Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!